Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer.

Xu, Fei; Tang, Qianqian; Wang, Yejinpeng; Wang, Gang; Qian, Kaiyu; Ju, Lingao; Xiao, Yu

Xu, Fei; Tang, Qianqian; Wang, Yejinpeng; Wang, Gang; Qian, Kaiyu; Ju, Lingao; Xiao, Yu.

Afiliación

Xu F; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Tang Q; Department of Breast and Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wang Y; Laboratory of Precision Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wang G; Laboratory of Precision Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Qian K; Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Ju L; Human Genetic Resource Preservation Center of Hubei Province, Wuhan, China.
Xiao Y; Human Genetic Resource Preservation Center of Wuhan University, Wuhan, China.

Front Genet ; 12: 758612, 2021.

Article en En | MEDLINE | ID: mdl-34938313

Palabras clave

bioinformatics analysis; biomarkers; bladder cancer; cancer-specific survival; six-gene prognostic signature

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Genet Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google